2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
Abstract Cytosolic phospholipase A2 (GIVA cPLA2) is the only PLA2 that exhibits a marked preference for hydrolysis of arachidonic acid containing phospholipid substrates releasing free arachidonic acid and lysophospholipids and giving rise to the generation of diverse lipid mediators involved in inf...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0316803c50ec492b8ba589202502cf1b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0316803c50ec492b8ba589202502cf1b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0316803c50ec492b8ba589202502cf1b2021-12-02T12:30:17Z2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A210.1038/s41598-017-07330-52045-2322https://doaj.org/article/0316803c50ec492b8ba589202502cf1b2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-07330-5https://doaj.org/toc/2045-2322Abstract Cytosolic phospholipase A2 (GIVA cPLA2) is the only PLA2 that exhibits a marked preference for hydrolysis of arachidonic acid containing phospholipid substrates releasing free arachidonic acid and lysophospholipids and giving rise to the generation of diverse lipid mediators involved in inflammatory conditions. Thus, the development of potent and selective GIVA cPLA2 inhibitors is of great importance. We have developed a novel class of such inhibitors based on the 2-oxoester functionality. This functionality in combination with a long aliphatic chain or a chain carrying an appropriate aromatic system, such as the biphenyl system, and a free carboxyl group leads to highly potent and selective GIVA cPLA2 inhibitors (X I(50) values 0.00007–0.00008) and docking studies aid in understanding this selectivity. A methyl 2-oxoester, with a short chain carrying a naphthalene ring, was found to preferentially inhibit the other major intracellular PLA2, the calcium-independent PLA2. In RAW264.7 macrophages, treatment with the most potent 2-oxoester GIVA cPLA2 inhibitor resulted in over 50% decrease in KLA-elicited prostaglandin D2 production. The novel, highly potent and selective GIVA cPLA2 inhibitors provide excellent tools for the study of the role of the enzyme and could contribute to the development of novel therapeutic agents for the treatment of inflammatory diseases.Maroula G. KokotouGerasimia GaliatsatouVictoria MagriotiGiorgos KoutoulogenisEfrosini BarbayianniDimitris LimniosVarnavas D. MouchlisBanita SatpathyAaron NavratilEdward A. DennisGeorge KokotosNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-16 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Maroula G. Kokotou Gerasimia Galiatsatou Victoria Magrioti Giorgos Koutoulogenis Efrosini Barbayianni Dimitris Limnios Varnavas D. Mouchlis Banita Satpathy Aaron Navratil Edward A. Dennis George Kokotos 2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2 |
description |
Abstract Cytosolic phospholipase A2 (GIVA cPLA2) is the only PLA2 that exhibits a marked preference for hydrolysis of arachidonic acid containing phospholipid substrates releasing free arachidonic acid and lysophospholipids and giving rise to the generation of diverse lipid mediators involved in inflammatory conditions. Thus, the development of potent and selective GIVA cPLA2 inhibitors is of great importance. We have developed a novel class of such inhibitors based on the 2-oxoester functionality. This functionality in combination with a long aliphatic chain or a chain carrying an appropriate aromatic system, such as the biphenyl system, and a free carboxyl group leads to highly potent and selective GIVA cPLA2 inhibitors (X I(50) values 0.00007–0.00008) and docking studies aid in understanding this selectivity. A methyl 2-oxoester, with a short chain carrying a naphthalene ring, was found to preferentially inhibit the other major intracellular PLA2, the calcium-independent PLA2. In RAW264.7 macrophages, treatment with the most potent 2-oxoester GIVA cPLA2 inhibitor resulted in over 50% decrease in KLA-elicited prostaglandin D2 production. The novel, highly potent and selective GIVA cPLA2 inhibitors provide excellent tools for the study of the role of the enzyme and could contribute to the development of novel therapeutic agents for the treatment of inflammatory diseases. |
format |
article |
author |
Maroula G. Kokotou Gerasimia Galiatsatou Victoria Magrioti Giorgos Koutoulogenis Efrosini Barbayianni Dimitris Limnios Varnavas D. Mouchlis Banita Satpathy Aaron Navratil Edward A. Dennis George Kokotos |
author_facet |
Maroula G. Kokotou Gerasimia Galiatsatou Victoria Magrioti Giorgos Koutoulogenis Efrosini Barbayianni Dimitris Limnios Varnavas D. Mouchlis Banita Satpathy Aaron Navratil Edward A. Dennis George Kokotos |
author_sort |
Maroula G. Kokotou |
title |
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2 |
title_short |
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2 |
title_full |
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2 |
title_fullStr |
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2 |
title_full_unstemmed |
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2 |
title_sort |
2-oxoesters: a novel class of potent and selective inhibitors of cytosolic group iva phospholipase a2 |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/0316803c50ec492b8ba589202502cf1b |
work_keys_str_mv |
AT maroulagkokotou 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT gerasimiagaliatsatou 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT victoriamagrioti 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT giorgoskoutoulogenis 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT efrosinibarbayianni 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT dimitrislimnios 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT varnavasdmouchlis 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT banitasatpathy 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT aaronnavratil 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT edwardadennis 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 AT georgekokotos 2oxoestersanovelclassofpotentandselectiveinhibitorsofcytosolicgroupivaphospholipasea2 |
_version_ |
1718394376402501632 |